Related Experiment Video
Updated: Jul 26, 2026

A Volumetric Method for Quantification of Cerebral Vasospasm in a Murine Model of Subarachnoid Hemorrhage
Published on: July 28, 2018
Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis
Andreas Charidimou1, Toshio Imaizumi1, Solene Moulin1
1From the Stroke Research Centre (A.C., Y.Y., S.M.G., H.R.J., D.J.W.), Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; Hemorrhagic Stroke Research Program, Department of Neurology (A.C., A.B., E.E.S., A.V., S.M.G.), Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston; Department of Neurosurgery (T.I.), Kushiro City General Hospital, Hokkaido, Japan; Degenerative & Vascular Cognitive Disorders (S.M., B.C., C.C.), Univ Lille, Inserm, CHU Lille, France; Centre for Clinical Brain Sciences (N.S., R.A.-S.S.), University of Edinburgh, UK; Department of Neurology (A.P.), Cliniques Universitaires UCL Saint Luc; Department of Neurology (Y.V., P.L.), CHU Dinant Godinne, Université Catholique de Louvain; Institute of Neuroscience (Y.V., P.L.), Université Catholique de Louvain, Brussels, Belgium; Department of Clinical Neurosciences (J.-C.B.), University of Cambridge, Addenbrooke's Hospital, UK; UMR 894 INSERM-Université Paris 5 (J.-C.B.), Sorbonne Paris Cité, Paris, France; Department of Neurology (M.H.-G., J.M.), Hospital Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Spain; Department of Neurology (D.-W.K., J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (H.N.), Hiroshima Prefectural Hospital, Japan; and Hotchkiss Brain Institute (E.E.S.), University of Calgary, Canada.
Objective:
We evaluated recurrent intracerebral hemorrhage (ICH) risk in ICH survivors, stratified by the presence, distribution, and number of cerebral microbleeds (CMBs) on MRI (i.e., the presumed causal underlying small vessel disease and its severity).
Methods:
This was a meta-analysis of prospective cohorts following ICH, with blood-sensitive brain MRI soon after ICH. We estimated annualized recurrent symptomatic ICH rates for each study and compared pooled odds ratios (ORs) of recurrent ICH by CMB presence/absence and presumed etiology based on CMB distribution (strictly lobar CMBs related to probable or possible cerebral amyloid angiopathy [CAA] vs non-CAA) and burden (1, 2-4, 5-10, and >10 CMBs), using random effects models.
Results:
We pooled data from 10 studies including 1,306 patients: 325 with CAA-related and 981 CAA-unrelated ICH. The annual recurrent ICH risk was higher in CAA-related ICH vs CAA-unrelated ICH (7.4%, 95% confidence interval [CI] 3.2-12.6 vs 1.1%, 95% CI 0.5-1.7 per year, respectively; p = 0.01). In CAA-related ICH, multiple baseline CMBs (versus none) were associated with ICH recurrence during follow-up (range 1-3 years): OR 3.1 (95% CI 1.4-6.8; p = 0.006), 4.3 (95% CI 1.8-10.3; p = 0.001), and 3.4 (95% CI 1.4-8.3; p = 0.007) for 2-4, 5-10, and >10 CMBs, respectively. In CAA-unrelated ICH, only >10 CMBs (versus none) were associated with recurrent ICH (OR 5.6, 95% CI 2.1-15; p = 0.001). The presence of 1 CMB (versus none) was not associated with recurrent ICH in CAA-related or CAA-unrelated cohorts.
Conclusions:
CMB burden and distribution on MRI identify subgroups of ICH survivors with higher ICH recurrence risk, which may help to predict ICH prognosis with relevance for clinical practice and treatment trials.
Insights
Cerebral microbleeds (CMBs) on MRI indicate higher recurrent intracerebral hemorrhage (ICH) risk in survivors. Higher CMB burden and lobar distribution, especially in cerebral amyloid angiopathy-related ICH, predict increased risk.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
- Vascular Neurology
Background:
- Intracerebral hemorrhage (ICH) survivors face a significant risk of recurrence.
- Cerebral microbleeds (CMBs) on MRI are markers of underlying small vessel disease and its severity.
- Understanding the relationship between CMBs and recurrent ICH is crucial for risk stratification.
Purpose of the Study:
- To evaluate the risk of recurrent intracerebral hemorrhage (ICH) in ICH survivors.
- To stratify this risk based on the presence, distribution, and number of cerebral microbleeds (CMBs) detected by MRI.
- To assess the role of CMBs in predicting ICH recurrence, differentiating between cerebral amyloid angiopathy (CAA)-related and non-CAA ICH.
Main Methods:
- A meta-analysis of 10 prospective cohort studies involving 1,306 patients with ICH.
- Blood-sensitive MRI was performed soon after the initial ICH event.
- Annualized recurrent ICH rates were estimated and compared using random effects models, analyzing CMB presence, distribution (lobar vs. non-lobar), and burden (number of CMBs).
Main Results:
- The annual recurrent ICH risk was significantly higher in CAA-related ICH (7.4%) compared to CAA-unrelated ICH (1.1%).
- In CAA-related ICH, multiple CMBs (≥2) were associated with increased ICH recurrence risk (ORs ranging from 3.1 to 4.3).
- In CAA-unrelated ICH, only a high CMB burden (>10) was associated with recurrent ICH (OR 5.6); one CMB was not associated with recurrence in either group.
Conclusions:
- CMB burden and distribution on MRI effectively identify ICH survivors at higher risk of recurrence.
- These imaging findings can aid in predicting ICH prognosis.
- This risk stratification has potential relevance for clinical practice and the design of future treatment trials.
Related Concept Videos
Stroke: Introduction and Types
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

